3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
US7541367B2 · kind B2 · utility
98Cited by
8References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 31, 2006 |
| Grant date | Jun 2, 2009 |
| Priority date | — |
| Expiry date | Dec 8, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to novel 3-benzoimidazolyl-pyrazolopyridine compounds of formula (I):and pharmaceutically acceptable forms thereof and their synthesis and use as inhibitors of serine-threonine protein kinases and tyrosine protein kinases and interactions thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.